AWS Summit: A Peek at the ‘One FDA’ Plan to Modernize Tech Procurement
Acquisition leader Joseph Montgomery shares how AI and cloud technologies informed the agency’s new strategy.
The Food and Drug Administration recently released a new acquisition strategy that aims to transform how the agency buys technology to impact multiple mission areas. In an interview with FDA Office of Enterprise Portfolio Management Director Joseph Montgomery at AWS Summit, he highlights the importance of this strategy to create a “one FDA” ecosystem that prioritizes advanced technology and keeping pace with IT innovation.
Montgomery also highlights how he’s thinking about artificial intelligence, cybersecurity and cloud to impact financial operations (FinOps) and ultimately support FDA’s modernization goals.
Check out our full conference coverage.
This is a carousel with manually rotating slides. Use Next and Previous buttons to navigate or jump to a slide with the slide dots
-
White House AI Framework Prioritizes Innovation, Calls for Fewer Barriers
The framework focuses on accelerating innovation through regulatory sandboxes, open data and streamlined federal policy.
3m read -
Federal Agencies Push AI‑Enabled Zero Trust to Outpace Adversaries
Officials warn that cultural resistance is among the biggest barriers to modernizing security architectures across government.
4m read -
Building the Military Health System’s AI Ecosystem
DHA and Red Hat discuss building a secure AI ecosystem, strengthening data foundations and ensuring safe AI use in military health care.
10m watch -
Geopolitical Tensions Highlight Need for Resilient AI Supply Chains
The U.S. is working with global partners to strengthen AI supply chains and ensure continuity amid growing geopolitical risks.
3m read
